中国药师
中國藥師
중국약사
CHINA PHARMACIST
2015年
5期
816-818
,共3页
案例分析%临床药师%SOAP会诊
案例分析%臨床藥師%SOAP會診
안례분석%림상약사%SOAP회진
Case analysis%Clinical pharmacist%SOAP consultation
目的::探讨临床药师进行SOAP模式药学会诊中的思维训练与经验积累过程。方法:对1例食管癌术后鲍曼不动杆菌肺炎患者进行病情变化评估,3次受邀会诊,建议药物治疗方案,监护药物治疗结果,连续1个月主动追踪并回访患者的病情转归结果。结果:鲍曼不动杆菌的初始判断与经验治疗后,感染有所好转,随着病情变化,及时调整治疗方案,依据病情和感染严重程度给予最适当的药物治疗方案,感染有效控制,术后治疗35 d出院。结论:临床药师会诊应首先判断病情,对前期治疗结果进行总结评估,再针对PK/PD特点选择药物,并不断追踪治疗结果,才能准确评估病情,做到个体化给药。
目的::探討臨床藥師進行SOAP模式藥學會診中的思維訓練與經驗積纍過程。方法:對1例食管癌術後鮑曼不動桿菌肺炎患者進行病情變化評估,3次受邀會診,建議藥物治療方案,鑑護藥物治療結果,連續1箇月主動追蹤併迴訪患者的病情轉歸結果。結果:鮑曼不動桿菌的初始判斷與經驗治療後,感染有所好轉,隨著病情變化,及時調整治療方案,依據病情和感染嚴重程度給予最適噹的藥物治療方案,感染有效控製,術後治療35 d齣院。結論:臨床藥師會診應首先判斷病情,對前期治療結果進行總結評估,再針對PK/PD特點選擇藥物,併不斷追蹤治療結果,纔能準確評估病情,做到箇體化給藥。
목적::탐토림상약사진행SOAP모식약학회진중적사유훈련여경험적루과정。방법:대1례식관암술후포만불동간균폐염환자진행병정변화평고,3차수요회진,건의약물치료방안,감호약물치료결과,련속1개월주동추종병회방환자적병정전귀결과。결과:포만불동간균적초시판단여경험치료후,감염유소호전,수착병정변화,급시조정치료방안,의거병정화감염엄중정도급여최괄당적약물치료방안,감염유효공제,술후치료35 d출원。결론:림상약사회진응수선판단병정,대전기치료결과진행총결평고,재침대PK/PD특점선택약물,병불단추종치료결과,재능준학평고병정,주도개체화급약。
Objective:To discuss the experience accumulation and thinking tralning of clinical pharmacist in the pharmaceutical consultation with SOAP model. Methods:Clinical pharmacist performed the condition evaluation for one patient with Acinetobacter bau-rnannii infection after esophagus cancer surgery and was invited to the consultation for three times. Clinical pharmacist also provided the references for the drug treatment and monitored the whole process. Clinical pharmacist actively followed and pald return visits for the prognosis of the patient for one month. Results: After identifying the pathogen, the experiential therapy was given and the condi-tions of the patient were improved. According to the changes of the conditions, the treatment was adjusted in time with the most suitable drugs for the conditions and infection degree. Finally, the infection was controlled effectively, and the patient was discharged after the 35-day postoperative treatment. Conclusion:During the consultation, clinical pharmacist should correctly judge the conditions of pa-tients, summarize and evaluate the earlier therapy results, and then choose suitable drugs according to the property of PK/PD. Clinical pharmacist also should track the therapy results to assess the conditions of patients and individualize the treatment.